6IO Stock Overview
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Inogen, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$6.45 |
52 Week High | US$12.40 |
52 Week Low | US$4.00 |
Beta | 1.08 |
1 Month Change | 3.20% |
3 Month Change | 34.38% |
1 Year Change | -44.87% |
3 Year Change | -87.60% |
5 Year Change | -91.35% |
Change since IPO | -96.59% |
Recent News & Updates
Recent updates
Shareholder Returns
6IO | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -5.1% | -5.1% | -1.5% |
1Y | -44.9% | -9.0% | 0.9% |
Return vs Industry: 6IO underperformed the German Medical Equipment industry which returned -6.2% over the past year.
Return vs Market: 6IO underperformed the German Market which returned -0.4% over the past year.
Price Volatility
6IO volatility | |
---|---|
6IO Average Weekly Movement | 14.4% |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6IO's share price has been volatile over the past 3 months.
Volatility Over Time: 6IO's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 834 | Kevin R. Smith | www.inogen.com |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories.
Inogen, Inc. Fundamentals Summary
6IO fundamental statistics | |
---|---|
Market cap | €152.31m |
Earnings (TTM) | -€96.25m |
Revenue (TTM) | €296.56m |
0.5x
P/S Ratio-1.6x
P/E RatioIs 6IO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6IO income statement (TTM) | |
---|---|
Revenue | US$315.66m |
Cost of Revenue | US$188.96m |
Gross Profit | US$126.70m |
Other Expenses | US$229.15m |
Earnings | -US$102.45m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
Earnings per share (EPS) | -4.39 |
Gross Margin | 40.14% |
Net Profit Margin | -32.46% |
Debt/Equity Ratio | 0% |
How did 6IO perform over the long term?
See historical performance and comparison